Cardinal Health, Inc. (CAH)
| Market Cap | 38.52B |
| Revenue (ttm) | 222.29B |
| Net Income (ttm) | 1.56B |
| Shares Out | 238.68M |
| EPS (ttm) | 6.38 |
| PE Ratio | 25.30 |
| Forward PE | 17.86 |
| Dividend | $2.04 (1.27%) |
| Ex-Dividend Date | Jul 1, 2025 |
| Volume | 2,722,230 |
| Open | 161.32 |
| Previous Close | 160.52 |
| Day's Range | 160.19 - 162.94 |
| 52-Week Range | 93.17 - 162.94 |
| Beta | 0.68 |
| Analysts | Buy |
| Price Target | 154.07 (-4.55%) |
| Earnings Date | Aug 13, 2025 |
About CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare... [Read more]
Financial Performance
In 2024, Cardinal Health's revenue was $226.83 billion, an increase of 10.66% compared to the previous year's $204.98 billion. Earnings were $852.00 million, an increase of 158.18%.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for CAH stock is "Buy." The 12-month stock price forecast is $154.07, which is a decrease of -4.55% from the latest price.
News
CAH CFO on Pharmaceutical Distributor's Outlook
Aaron Alt, CFO at Cardinal Health (CAH), joins Diane King Hall at the NYSE set to discuss the company's financial outlook. He describes the drugmaker's share buyback plans and recent FY25 guidance rai...
Cardinal Health raises annual profit target
Drug distributor Cardinal Health raised its annual adjusted profit forecast on Thursday, banking on demand for costly specialty medicines and branded drugs at its pharmaceuticals unit.
Cardinal Health Details Momentum and Updated Long-Term Value Creation Plans at Investor Day
Key announcements: Raising FY25 non-GAAP diluted EPS guidance to $8.15 to $8.20 1 Establishing preliminary FY26 non-GAAP diluted EPS guidance of $9.10 to $9.30 (13% growth at the mid-points)2 Confirmi...
Cardinal Health Analyst Flags Fading Scale Gap, Sees Rising Edge in Specialty Growth
BofA Securities analyst Allen Lutz reiterated the Buy rating on Cardinal Health, Inc. CAH, raising the price forecast from $165 to $170.
Cramer's Stop Trading: Cardinal Health
Jim Cramer breaks down why he's keeping an eye on shares of Cardinal Health.
Cardinal Health launches new medical device for the continuous monitoring of three essential vital signs in one system
Kendall DL™ Multi System simplifies patient monitoring, drives efficiencies for providers DUBLIN, Ohio , June 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of it...
Best Dividend Aristocrats For June 2025
Dividend Aristocrats have slightly outperformed the S&P 500 year-to-date, despite underperforming in April and May. Dividend growth remains robust, with 41 of 69 Aristocrats announcing increases in 20...
Cardinal Health releases new report on the cell and gene therapy industry
Analysis charts the emergence and future of advanced therapies DUBLIN, Ohio , May 7, 2025 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizin...
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio , May 5, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5107 per share, out of the Comp...
Cardinal Health, Northrop Grumman Among 7 Companies To Announce Dividend Increases In First Half Of May
This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. Industrial engineering company Parker-Hannifin announced i...
Cardinal Health Lifts FY25 EPS Outlook, Sees Growth Despite Tariff Risks
Cardinal Health Inc. CAH on Thursday reported third-quarter 2025 adjusted EPS of $2.35, up 13% year over year, beating the consensus of $2.17.
Cardinal Health, Inc. (CAH) Q3 2025 Earnings Call Transcript
Cardinal Health, Inc. (NYSE:CAH) Q3 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Matt Sims - Vice President, Investor Relations Jason Hollar - Chief Executive Officer Aar...
Cardinal Health lifts full-year profit forecast again on specialty medicine sales
Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast for the fourth time, betting on strong demand for costly specialty medicines and branded drugs.
Cardinal Health Reports Third Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook
Revenue was flat at $54.9 billion; revenue increased 19% excluding the impact of the previously communicated customer contract expiration GAAP 1 operating earnings were $730 million; GAAP diluted EPS ...
Best Dividend Aristocrats For May 2025
Despite a strong start, the Dividend Aristocrats are underperforming the S&P 500 in April, with NOBL down 4.88% and SPY down 1.53%. The best-performing Dividend Aristocrats YTD include Consolidated Ed...
ESG Still Matters. 3 Defensive Stocks That Make the Grade.
Cardinal Health, Atmos Energy, and General Mills make the cut for one ESG fund manager.
Best Dividend Aristocrats For April 2025
Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Br...
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2025 on May 1
DUBLIN, Ohio , March 25, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2025 on May 1, prior to the opening of trading on the New...
Cardinal Health, Inc. (CAH) Leerink's 2025 Global Healthcare Conference (Transcript)
Cardinal Health, Inc. (NYSE:CAH) Leerink's 2025 Global Healthcare Conference Call March 12, 2025 8:40 AM ET Company Participants Aaron Alt - Chief Financial Officer Matt Sims - Investor Relations Con...
Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors
DUBLIN, Ohio , March 10, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Health...
The Dividend Aristocrats Ranked By Quality Scores: March 2025
S&P Dow Jones Indices added three new members to the S&P 500 Dividend Aristocrats Index, expanding it to 69 companies. I rank Dividend Aristocrats by quality scores, presenting undervalued and overval...
Cardinal Health Analysts Raise Their Forecasts Following Upbeat Earnings
Cardinal Health CAH reported better-than-expected second-quarter financial results on Thursday.
Cardinal Health, Inc. (CAH) Q2 2025 Earnings Call Transcript
Cardinal Health, Inc. (NYSE:CAH) Q2 2025 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Matt Sims - Vice President, Investor Relations Jason Hollar - Chief Executive Office...
Cardinal Health lifts 2025 profit forecast on specialty drugs demand
Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.